Drug developers can now leverage large language models to draft regulatory documents, which they hope will shorten the time ...

Genmab A/S (Nasdaq: GMAB) announced today that AbbVie Inc. (AbbVie) has filed a complaint in the U.S. District Court for the Western District of Washington (Seattle) naming Genmab A/S; ProfoundBio US ...

ADC Therapeutics' primary focus is on the CD19-targeted antibody-drug conjugate Zynlonta. Read why ADCT stock is rated as a ...

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

What should be done with all the wood and plastic waste? This has been investigated by Supriyanto, Ph.D. in the research area ...

With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS’ Saint-Beauzire site provides tailored solutions for pre-clinical and clinical trials and small ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

AbbVie claims that Genmab divulged key trade secrets to support the development of ProfoundBio’s investigational ...

Britta Späth has dedicated her career to proving a single, central conjecture. She’s finally succeeded, alongside her partner ...

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

A team of Chinese researchers has developed a new interfacial synthesis strategy to fabricate high-performance crystalline ...